CMA1 and prostate cancer: CYM also decreased the percentage of TRA-1-81+ cells in other cancer cell lines, e.g. prostate cancer cell line DU145 (Supplementary Figure S5F, left) and colorectal cancer cell line HCT-116 (Supplementary Figure S5F, right).